Amgen Inc. (LON:0R0T)
London
· Delayed Price · Currency is GBP · Price in USD 344.55
+6.03 (1.78%)
At close: Dec 3, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Prolia Revenue | 4.53B | 4.37B |
Log In |
Log In |
Log In | Upgrade
|
| ENBREL Revenue | 2.71B | 3.32B |
Log In |
Log In |
Log In | Upgrade
|
| XGEVA Revenue | 2.20B | 2.23B |
Log In |
Log In |
Log In | Upgrade
|
| Repatha Revenue | 2.75B | 2.22B |
Log In |
Log In |
Log In | Upgrade
|
| Otezla Revenue | 2.26B | 2.13B |
Log In |
Log In |
Log In | Upgrade
|
| TEPEZZA Revenue | 1.91B | 1.85B |
Log In |
Log In |
Log In | Upgrade
|
| EVENITY Revenue | 1.93B | 1.56B |
Log In |
Log In |
Log In | Upgrade
|
| KYPROLIS Revenue | 1.43B | 1.50B |
Log In |
Log In |
Log In | Upgrade
|
| Nplate Revenue | 1.48B | 1.46B |
Log In |
Log In |
Log In | Upgrade
|
| Aranesp Revenue | 1.36B | 1.34B |
Log In |
Log In |
Log In | Upgrade
|
| BLINCYTO Revenue | 1.53B | 1.22B |
Log In |
Log In |
Log In | Upgrade
|
| KRYSTEXXA Revenue | 1.25B | 1.19B |
Log In |
Log In |
Log In | Upgrade
|
| Vectibix Revenue | 1.10B | 1.05B |
Log In |
Log In |
Log In | Upgrade
|
| TEZSPIRE Revenue | 1.30B | 972.00M |
Log In |
Log In |
Log In | Upgrade
|
| Other Products Revenue | 6.76B | 5.63B |
Log In |
Log In |
Log In | Upgrade
|
| Product Revenue | 34.50B | 32.03B |
Log In |
Log In |
Log In | Upgrade
|
| Other Revenue | 1.47B | 1.40B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -3.16B | -3.04B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 35.97B | 33.42B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| U.S. Revenue | - | 23.86B |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World (ROW) Revenue | - | 9.56B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 35.97B | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 35.97B | 33.42B |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2019 |
| McKesson Corporation Revenue | 22.17B |
Log In |
Log In |
Log In | Upgrade
|
| Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue | 18.39B |
Log In |
Log In |
Log In | Upgrade
|
| Cardinal Health, Inc. Revenue | 11.28B |
Log In |
Log In |
Log In | Upgrade
|